Avanos Medical, Inc. (AVNS) Stock Analysis
Range Bound setup
Healthcare · Medical Devices
Hold if already holding. Not a fresh buy at $24.93, but acceptable to hold if already in. Reason: Near 52-week high (2.2% away).
Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding... Read more
Hold if already holding. Not a fresh buy at $24.93, but acceptable to hold if already in. Reason: Near 52-week high (2.2% away). Chart setup: RSI 47 mid-range, Bollinger mid-band. Mixed signals. Hold existing position. Score 5.6/10, moderate confidence.
Passes 5/7 gates (clean insider activity, no SEC red flags, earnings proximity 37d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum. Suitability: aggressive.
Recent developments
updated 2026-07-05Recent Developments — Avanos Medical, Inc.
Latest news
- NEWS Avanos Medical And American Industrial Partners Obtain Required Regulatory Approvals For Pending Merger — benzinga Jul 2, 2026 positive
Generated 2026-07-05T09:50:25Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
1 floor-breaker
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $24.93, but acceptable to hold if already in. Reason: Near 52-week high (2.2% away). Chart setup: RSI 47 mid-range, Bollinger mid-band. Mixed signals. Hold existing position. Target $24.60 (-1.3%), stop $24.71 (−0.9%), A.R:R 0.0:1. Score 5.6/10, moderate confidence.
Take-profit target: $24.60 (-1.3% upside). Target $24.60 (-1.3%), stop $24.71 (−0.9%), A.R:R 0.0:1. Stop-loss: $24.71.
Near 52-week high (2.2% away).
Avanos Medical, Inc. trades at a P/E of N/A (forward 19.9). TrendMatrix value score: 6.8/10. Verdict: Hold.
6 analysts cover AVNS with a consensus score of 2.2/5.
What does Avanos Medical, Inc. do?Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the...
Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides non-opioid pain solutions, including surgical pain and recovery products, which comprise ON-Q and ambIT surgical pain pump, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which provide minimally invasive pain-relieving therapies, such as COOLIEF chronic pain products; and Trident and Esentec RFA radiofrequency ablation products to treat chronic pain conditions. The company markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. Avanos Medical, Inc. was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. The company was incorporated in 2014 and is headquartered in Alpharetta, Georgia.